Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.45    -0.20 (-1.20%)
Bid:
16.45
Ask:
16.70
Spread: 0.25 (1.52%)
Market Cap: £131.85m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Contract Win

30 Jan 2014 07:00

RNS Number : 8308Y
Allocate Software PLC
30 January 2014
Β 

ο»Ώ

Β 

RNS REACH

Β 

Β 

30 January 2014

Β 

Allocate Software plc

Β 

("Allocate" or the "Company")

Contract Win

Β 

Β 

Barts Health NHS Trust responds to the challenges of delivering safe and effective care by adopting a single system to manage staff rotas fairly and safely.

Β 

Barts Health NHS Trust, England's largest NHS Trust with over 15,000 staff, is moving to a new electronic workforce system which will make it easier than ever before to ensure wards are staffed safely and with the appropriate skill mix.

Β 

The formation of Barts Health in 2012 saw the merger of six hospitals with a variety of tracking and rostering tools. Having conducted a lengthy selection exercise, the Trust is now working in partnership with Allocate Software to implement one Trust-wide system.

Β 

Using Allocate Software's HealthSuite software, including its HealthRoster and HealthMedics solutions, Barts Health aims to replace existing paper records and spreadsheets to rota all staff groups including nurses and medics. The new system will also help to reduce expenditure and reliance on Bank and Agency staff, helping the Trust to meet its commitment to employ 95 per cent permanent staff.

Β 

Allocate Software's HealthRoster suite will help the Trust in a number of ways, including:

Β 

- providing a single system that will help managers match demand to clinical need which ensures the right staff are available at the right time, managing absence and informing payroll;

- providing visibility and control of nurse staffing levels in relation to patient acuity and dependency as well as overall patient numbers;

- delivering a system for managing consultant job planning, medical availability, junior doctor rotas and clinical activity management which can then be integrated into other rosters for multi-disciplinary service environments;

- streamlining interaction with temporary staffing/agency services which will then use the system to manage booking of bank and agency staff as well as timesheet/payroll collation;

- empowering staff by providing online access to relevant documents (such as their annual leave calendar and request duty forms) so they can manage their responsibilities more effectively.

- assisting with the full visibility of staff utilization and absence management.

Β 

Allocate Software's HealthSuite will play a significant part in helping the Trust continue to meet the challenge of delivering safe, high quality care while ensuring staff have access to a system which will help them in their day-to-day roles.

Β 

Β 

Ian Bowles, Chief Executive Officer, Allocate Software, said:Β 

Β 

"It is important that an NHS Trust of this size is able to manage staff effectively and in real-time. HealthRoster will ensure the Trust can have a high level view of what is happening in every ward, theatre and clinic and department whilst at the same time allowing managers to drill down team by team to individual staff. We are very excited about the opportunity to help Barts Health gain this level of insight and understanding."

Β 

Human Resources Director at Barts Health NHS Trust, Michael Pantlin said:

Β 

"The trust believes its employees, our staff, are our most valuable resource. By integrating how we manage staff and patient numbers across our hospitals we will have greater visibility and control of our staff groups, ensuring we have the right staff to care for patients in the right place and at the right time.

Β 

"The online software will also give teams instant access to real-time staffing levels, patient numbers and the acuity and care needs of these patients, as well as schedules of clinical activity such as clinics and theatres."

Β 

Β 

Enquiries:

Β 

Allocate Software

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

Β 

Β 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

Β 

Β 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Matt Dixon, Chris Lane

Tel: +44 (0) 20 7831 3113

Β 

Β 

Notes to editors:

Β 

Allocate Software brings in-depth market knowledge and wide-ranging expertise to the development of innovative solutions that are designed to help the NHS become more efficient while maintaining and improving service quality. Our solutions are the most widely-used workforce management, governance and compliance tools in healthcare. HealthSuite solutions include e-Rostering with HealthRoster, medic workforce solutions with HealthMedics, risk and compliance with HealthAssure and PatientFlow and Emergency Department solutions with RealTime.

Β Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
NRAEAKFNASLLEFF
Date   Source Headline
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment
6th Sep 20237:00 amRNSResource and Exploration Drilling Results
4th Sep 20238:45 amRNSConference Attendance
30th Aug 20237:00 amRNSIssue of Equity - ESOP Options
22nd Aug 20237:00 amRNSIssue of Equity - Exercise of ESOP Options
17th Aug 20237:00 amRNSPartner Commits to Ewoyaa Development Funding
15th Aug 20237:00 amRNSMOU Signed for By-product Feldspar Study
10th Aug 20239:14 amRNSPCA Dealings
9th Aug 20239:30 amRNSDirector/PDMR Dealings
8th Aug 20237:00 amRNSResource and Exploration Drilling Results
7th Aug 20233:13 pmRNSStatement re Media Speculation
31st Jul 20237:00 amRNSQuarterly Activities and Cash Flow Report
19th Jul 20237:00 amRNSConference Attendance
13th Jul 20237:00 amRNSAppointment of Flotation Scoping Study Partner
30th Jun 20237:00 amRNSInvestor Presentation
29th Jun 20238:21 amRNSEwoyaa Definitive Feasibility Study
29th Jun 20237:17 amRNSEwoyaa Definitive Feasibility Study
23rd Jun 202311:00 amRNSBoard Appointments
20th Jun 20237:00 amRNSInitial Infill Drilling Results
16th Jun 20237:00 amRNSConference Attendance
13th Jun 20237:00 amRNSCorporate Update - Resignation of Director
1st Jun 20237:00 amRNSBoard Changes
26th May 20237:00 amRNSDTC Eligibility for OTCQX Electronic Trading
17th May 20237:00 amRNSConference Attendance
16th May 20237:00 amRNSAppointment of Chief Executive Officer
4th May 20237:00 amRNSConference Attendance
28th Apr 20237:00 amRNSQuarterly Activities and Cash Flow Report
26th Apr 20237:00 amRNSInternational Lithium Association Membership
19th Apr 20237:00 amRNSInfill Drilling and Passive Seismic Survey
6th Apr 20237:00 amRNSIssue of Equity – Exercise of ESOP Options
31st Mar 20237:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.